JSPR logo

JSPRJasper Therapeutics Inc

$0.4661
$0.0001
(0.02%)
Pre-Market
Updated: 04:27 AM EDT·Prev Close $0.466
Reported EarningsMay 14
Mkt Cap$13M
Vol212.00
News
all
press releases
Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate
Major M&A deals this week include: New Mountail Capital buys Asset Living, SalesForce acquires Contentful, Wellington nabs The Hartford Fundsread more...
Benzinga
News Placeholder
More News
News Placeholder
Bears are Losing Control Over Jasper Therapeutics (JSPR), Here's Why It's a 'Buy' Now
Jasper Therapeutics (JSPR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks
News Placeholder
FDA Extends Review Time for AZN's Camizestrant Combo in Breast Cancer
AstraZeneca faces a longer FDA review for camizestrant combo in a certain type of first-line breast cancer after regulators request additional data.
Zacks
News Placeholder
AZN, Daiichi's Enhertu Gets Positive CHMP Opinion for Solid Tumors
AstraZeneca and Daiichi's Enhertu wins CHMP backing for HER2-positive metastatic solid tumors. The camizestrant combo also gains a positive CHMP nod.
Zacks
News Placeholder
AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer
AstraZeneca and Daiichi Sankyo get FDA approval for Datroway's expanded use in triple-negative breast cancer treatment.
Zacks
News Placeholder
Jasper Therapeutics, Inc. (NASDAQ:JSPR) Short Interest Up 88.6% in December
Jasper Therapeutics, Inc. (NASDAQ:JSPR - Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totaling 3,455,246 shares, a...
MarketBeat
News Placeholder
Penny Stocks To Watch Now - December 2nd
Beyond Meat, Bitfarms, Fitell, Eventbrite, and Jasper Therapeutics are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small...
MarketBeat
News Placeholder
Jasper Stock Jumps After Promising New Asthma Study Results
Jasper Therapeutics released positive data from a study of subcutaneous briquilimab for allergic asthma treatment.read more...
Benzinga
News Placeholder
JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. (Jasper or the Company) (NASDAQ: JSPR) and reminds investors of the...
Business Wire
News Placeholder
Deadline Soon: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.